AstraZeneca AB

MAP Pharmaceuticals Reports Third Quarter of 2009 Financial Results.(Financial report)
Pediatrics Week; 11/21/2009; 1478 words; ...recognized upon the termination of the AstraZeneca AB license agreement in the third quarter...Pharmaceuticals' license agreement with AstraZeneca. On July 8, 2009, the company received notice from AstraZeneca of the termination of the license...

Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2010 Results; Teleconference and Webcast to be held on November 16, 2009.
PR Newswire; 11/16/2009; 2145 words; ...s license and clinical trial agreements with AstraZeneca AB (AstraZeneca) and a net decrease in operating expenses resulting...programs in 2008. In September 2009, Palatin and AstraZeneca signed an amendment to their exclusive research...

Publication No. WO/2009/136191 Published on Nov. 12, Assigned to ASTRAZENECA, ASTRAZENECA UK for Chemical Compound (American Inventors)
US Fed News Service, Including US State News; 11/13/2009; 424 words; ...United States of America, have developed chemical compounds. The patent has been assigned to ASTRAZENECA AB, Sodertalje, Sweden, and ASTRAZENECA UK LTD., Greater London, Great Britain. According to an abstract posted by the World Intellectual...

Regence Recognized as an American Heart Association Start! Fit-Friendly Company.
PR Newswire; 11/13/2009; 1153 words; ...University and nationally by SUBWAYA' Restaurants, Healthy ChoiceA' and AstraZeneca. For more information about the Start! Fit-Friendly Companies Program...please visit http://www.regence.com/ or follow us on Twitter. Ab

Patent No. 7,615,555 Issued on Nov. 10, Assigned to AstraZeneca for Piperidine Derivative (British Inventors)
US Fed News Service, Including US State News; 11/11/2009; 376 words; ...derivative. The inventors were issued U.S. Patent No. 7,615,555 on Nov. 10. The patent has been assigned to AstraZeneca AB, Sodertalje, Sweden. According to the abstract released by the U.S. Patent & Trademark Office: "Compounds...